OPENAI RESEARCHER LAUNCHES DRUG DISCOVERY STARTUP

Miles Wang, an OpenAI researcher focused on AI-accelerated scientific discovery, is departing the company to start a new AI drug discovery venture. The startup is in talks to raise $200 million at a $2 billion valuation.